Selected Publications
Heitzer AM, Longoria J, Rampersaud E, Rashkin SR, Estepp JH, Okhomina VI, Wang WC, Raches D, Potter B, Steinberg MH, King AA, Kang G,Hankins JS. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia. Curr Res Transl Med 70(3), 103335, 2022. doi:10.1016/j.retram.2022.103335
Trpchevska A, Longoria J, Okhomina V, Raches D, Potter B, Kang G, Heitzer AM, Hankins JS. Adaptive Functioning in Children and Adolescents With Sickle Cell Disease. Journal of Pediatric Psychology Apr 5;jsac024, 2022. doi:10.1093/jpepsy/jsac024
Heitzer AM, Cohen DL, Okhomina VI, Trpchevska A, Potter B, Longoria J, Porter JS, Estepp JH, King A, Henley M, Kang G, Hankins JS. Neurocognitive functioning in preschool children with sickle cell disease. Pediatric Blood & Cancer 69(3):e29531, 2022. doi:10.1002/pbc.29531
Boggs, J., Freeman, M., Okhomina, V. I., Kang, G., Heitzer, A. M., & Wang, W. C. (2022). Reading intervention targeting phonemic awareness and symbol imagery in children with sickle cell disease. Pediatric Blood & Cancer, 69(3), e29561. doi:10.1002/pbc.29561
Longoria JN, Heitzer AM, Hankins JS, Trpchevska A, Porter JS. Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations. British Journal of Haematology Feb 4, 2022. doi:10.1111/bjh.18041
Champlin G, Hwang SN, Heitzer A, Ding J, Jacola L, Estepp JH, Wang W, Ataga KI, Owens CL, Newman J, King AA, Davis R, Kang G, Hankins JS. Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia. Experimental Biology and Medicine (Maywood, NJ) 246(23):2473-2479, 2021. doi:10.1177/15353702211035778
Heitzer AM, Hamilton L, Stafford C, Gossett J, Ouellette L, Trpchevska A, King AA, Kang G, Hankins JS. Academic Performance of Children With Sickle Cell Disease in the United States: A Meta-Analysis. Frontiers in Neurology 12:786065, 2021. doi:10.3389/fneur.2021.786065
Wang WC, Zou P, Hwang SN, Kang G, Ding J, Heitzer AM, Schreiber JE, Helton K, Hankins JS. Effects of hydroxyurea on brain function in children with sickle cell anemia. Pediatric Blood & Cancer 68(10):e29254, 2021. doi:10.1002/pbc.29254
Heitzer AM, Longoria J, Okhomina V, Wang WC, Raches D, Potter B, Jacola LM, PorterJ, Schreiber JE, King AA, Kang G, Hankins JS. Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood. British Journal of Haematology 195(2):256-266, 2021. doi:10.1111/bjh.17687
Wang W, Freeman M, Hamilton L, Carroll Y, Kang G, Moen J, Smeltzer MP, Schreiber J, Heitzer AM, Estepp J, Aygun B. Developmental screening of three-year-old children with sickle cell disease compared to controls. British Journal of Haematology 195(4):621-628, 2021. doi:10.1111/bjh.17780
Last update: April 2022